Hao Sibin, Liu Yunpeng, Yu Mingtai, Sun Fang, Wang Dezhang
Department of Hand and Foot Surgery, Jinan Zhangqiu District People's Hospital, Jinan, China.
Evid Based Complement Alternat Med. 2022 Jun 28;2022:1294416. doi: 10.1155/2022/1294416. eCollection 2022.
To assess the efficacy of targeted perioperative management for diabetic patients with traumatic calcaneal fractures.
Between April 2020 and December 2020, 100 diabetic patients with traumatic calcaneal fractures treated in our institution satisfying the inclusion criteria were enrolled and assigned to receive either conventional treatment with surgery or plaster fixation (observation group) or targeted treatment with surgery or plaster fixation (experimental group) via the random number table method, with 50 patients in each group. All eligible patients were followed up for 1 year postoperatively. Outcome measures included length of hospital stay, recovery time, fracture healing, duration of postoperative wound drainage, complication rate, blood glucose, and treatment satisfaction. The Maryland score was used for the assessment of foot function.
The duration of postoperative wound drainage, length of hospital stay, and recovery time in the experimental group (3.63 ± 1.04 d, 12.13 ± 3.77 d, and 111.22 ± 16.24 d) were significantly shorter than those in the observation group (5.71 ± 2.34 d, 15.28 ± 4.42 d, 123.10 ± 22.82 d) ( < 0.01). The experimental group obtained a markedly higher complete healing rate versus the observation group ( < 0.001). A significantly lower complication rate was observed in the experimental group than in the observation group ( < 0.05). The Maryland scores results were dichotomized into good (≥75 points) and poor (<75 points). The experimental group showed significantly higher Maryland scores good rate and treatment satisfaction versus the observation group ( < 0.01). The experimental group patients were associated with better postoperative fasting glucose and 2 h postprandial glucose versus those in the observation group ( < 0.05).
Targeted treatment in the perioperative management of diabetic patients with traumatic calcaneal fractures significantly promotes the recovery of patients, reduces the incidence of complications, increases treatment satisfaction, and ameliorates the doctor-patient relationship.
评估针对糖尿病合并创伤性跟骨骨折患者的围手术期靶向治疗的疗效。
2020年4月至2020年12月期间，选取在我院接受治疗且符合纳入标准的100例糖尿病合并创伤性跟骨骨折患者，通过随机数字表法将其分为两组，每组50例。一组接受手术或石膏固定的传统治疗（观察组），另一组接受手术或石膏固定的靶向治疗（试验组）。所有符合条件的患者术后随访1年。观察指标包括住院时间、恢复时间、骨折愈合情况、术后伤口引流持续时间、并发症发生率、血糖水平以及治疗满意度。采用马里兰评分评估足部功能。
试验组术后伤口引流持续时间、住院时间和恢复时间（分别为3.63±1.04天、12.13±3.77天和111.22±16.24天）显著短于观察组（分别为5.71±2.34天、15.28±4.42天、123.10±22.82天）（P<0.01）。试验组的完全愈合率明显高于观察组（P<0.001）。试验组的并发症发生率显著低于观察组（P<0.05）。马里兰评分结果分为良好（≥75分）和较差（<75分）。试验组的马里兰评分良好率和治疗满意度显著高于观察组（P<0.01）。试验组患者术后空腹血糖和餐后2小时血糖水平优于观察组（P<0.05）。
糖尿病合并创伤性跟骨骨折患者围手术期的靶向治疗可显著促进患者康复，降低并发症发生率，提高治疗满意度，并改善医患关系。
